About Vencarm XL
Welcome to vencarm.co.uk
Vencarm XL is a prolonged-release capsule of venlafaxine indicated for the:1
Treatment of major depressive episodes
Prevention of recurrence of major depressive episodes
Treatment of generalised anxiety disorder
Treatment of social anxiety disorder
Treatment of panic disorder, with or without agoraphobia
Available as:
37.5mg prolonged-release capsules
75mg prolonged-release capsules
150mg prolonged-release capsules
225mg prolonged-release capsules
Vencarm XL is bioequivalent to the originator EFEXOR XL (venlafaxine prolonged-release capsules) (Pfizer Ltd) based on biostudies using TREVILOR® retard (Venlafaxine Hydrochloride Prolonged-release) Capsules, (Pfizer Pharma GmbH, Germany)2
jhbcxhqbchqwbichqbwichb
Vencarm XL could offer significant cost savings to your practice and clinical commissioning group (CCG).
venlafaxine 37.5mg, 75mg, 150mg and 225mg prolonged-release capsules are in category C of the UK Drug Tariff.3
However, the NHS could make up to 79% savings on the cost of category C venlafaxine by prescribing Vencarm XL by brand name.3*
Vencarm XL is one of Aspire Pharma’s cost saving prolonged-release products.
Quite simply a wholesale switch of venlafaxine prolonged-release 37.5mg, 75mg, 150mg and 225mg tablet and capsule prescriptions to Vencarm XL could save an average CCG £35,167 per year.4***
In addition:
Full range of strengths available for Vencarm XL;
Available from mainline wholesalers;
High level of stockholdings;
Bioequivalent to the originator brand;2
Price guaranteed**
*Based on up to 79% saving on the cost of Category C venlafaxine XL capsules and tablets in the UK Drug Tariff. **No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review. ***Savings based on market data in reference 4. Savings calculated from 2018 spend for 217 CCGs switching their generic and originator brand 37.5mg, 75mg, 150mg and 225mg venlafaxine prolonged-release tablets and capsules prescriptions to Vencarm XL.
References 1) Vencarm XL SmPCs. 2) Data on file. 1010344221 v 2.0 September 2019. 3) March 2020 UK Drug Tariff. 4) ePact data Jan-Dec 2018
TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: customerservices@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Vencarm XL (venlafaxine), please see the abbreviated prescribing information.
Revision reference – Vencarm XL_7_09.12.2020
